RARRES2 and ovarian cancer: The results of DNA microarray analyses of 1656 ovarian cancer patients, demonstrating a significantly decreased survival of patients with high chemerin tumor expression, seemed not to support this hypothesis, but it has to be considered that tumor tissue is only a minor source of chemerin.